Accordingly, cancer stem cell-like markers [38] and epithelial-mesenchymal transition (EMT) biomarkers (vimentin up-regulation and E-cadherin and β-catenin down-regulation) are associated with recurrence of OSCC patients [39]. This evidence concerns the gene VIM and cancer.